Active-Controlled Trial of the Safety and Tolerability of MP03-33 in Patients with Chronic Allergic or Nonallergic Rhinitis - NA
Active-Controlled Trial of the Safety and Tolerability of MP03-33 (Nasal Spray) in Patients with Chronic Allergic or Nonallergic Rhinitis
Active-Controlled Trial of the Safety and Tolerability of MP29-02 in Subjects with Chronic Allergic or Nonallergic Rhinitis
100 Clinical Results associated with Medpointe Pharmaceuticals
0 Patents (Medical) associated with Medpointe Pharmaceuticals
100 Deals associated with Medpointe Pharmaceuticals
100 Translational Medicine associated with Medpointe Pharmaceuticals